您的购物车当前为空
别名 IDX-184, IDX 184
IDX184 是一种有效的,具有口服活性的靶向 HCV 聚合酶抑制剂和核苷聚合酶抑制剂。IDX184 有效抑制 HCV 聚合酶 (IC50=0.31 μM,Ki=52.3 nM)。 IDX184是一种肝脏靶向核苷酸前药,具有抗HCV活性,可抑制HCV NS5B聚合酶,可与聚乙二醇化干扰素-α2a 和利巴韦林联合用于初治慢性丙型肝炎。


为众多的药物研发团队赋能,
让新药发现更简单!
IDX184 是一种有效的,具有口服活性的靶向 HCV 聚合酶抑制剂和核苷聚合酶抑制剂。IDX184 有效抑制 HCV 聚合酶 (IC50=0.31 μM,Ki=52.3 nM)。 IDX184是一种肝脏靶向核苷酸前药,具有抗HCV活性,可抑制HCV NS5B聚合酶,可与聚乙二醇化干扰素-α2a 和利巴韦林联合用于初治慢性丙型肝炎。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,330 | 现货 | |
| 5 mg | ¥ 3,360 | 现货 | |
| 10 mg | ¥ 4,890 | 现货 | |
| 25 mg | ¥ 7,680 | 现货 | |
| 50 mg | ¥ 9,870 | 现货 |
IDX184 相关产品
| 产品描述 | IDX184 is a potent, orally active, targeted HCV polymerase inhibitor and nucleoside polymerase.IDX184 effectively inhibits HCV polymerase (IC50=0.31 μM, Ki=52.3 nM). IDX184 is a liver-targeted nucleotide prodrug with anti-HCV activity that inhibits HCV NS5B polymerase and can be used in combination with pegylated interferon-α2a and ribavirin for the primary treatment of chronic hepatitis C. It has been shown to inhibit HCV polymerase and nucleoside polymerase. |
| 靶点活性 | HCV polymerase:52.3 nM (Ki), HCV polymerase:0.31 μM (IC50) |
| 体外活性 | IDX184, a liver-targeted prodrug of the nucleotide 2′-MeG-MP, serves as a hepatitis C virus polymerase inhibitor with liver-specific targeting.[1] |
| 别名 | IDX-184, IDX 184 |
| 分子量 | 626.62 |
| 分子式 | C25H35N6O9PS |
| CAS No. | 1036915-08-8 |
| Smiles | C[C@]1(O)[C@H](N2C3=C(N=C2)C(=O)N=C(N)N3)O[C@H](COP(NCC4=CC=CC=C4)(OCCSC(C(CO)(C)C)=O)=O)[C@H]1O |
| 密度 | 1.59 g/cm3 |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 50 mg/mL (79.79 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容